Naturally Splendid Receives Business Excellence Award from Chamber of Commerce

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) is pleased to announce The Maple Ridge-Pitt Meadows Chamber of Commerce has selected Naturally Splendid as the 2020 Business Excellence Awards winner in the Large Business of the Year category

Amongst the criteria considered, the judging committee recognized Naturally Splendid for our ability to navigate COVID-19, and respected how we chose to overcome the challenges we have faced during these difficult times. The judges were also intrigued by the many new and innovative ideas including our latest offering, NATERA Plant Based Foods, as well as for the overall passion we have for what we do.

Naturally Splendid operates a Safe Quality Food certified manufacturing facility in the municipality of Pitt Meadows through our 100% owned subsidiary, Prosnack Natural Foods.

Prosnack focuses on manufacturing a wide range of nutritious, plant-based bars and bites under several Company brands including NATERA Sport Key-To-Life keto friendly bars and Woods Wild mushroom fortified bars. Prosnack also contract manufactures for several clients whose bars are sold in major retailers across the country.

Naturally Splendid CEO Mr. J. Craig Goodwin states, "We are honoured to receive this award from The Maple Ridge-Pitt Meadows Chamber of Commerce. I am so pleased to see that amongst the accolades, the passion we have for what we do was recognized. In this regard, Naturally Splendid co-founder Bryan Carson and myself, along with the Board of Directors, would like to thank the hard-working employees at Naturally Splendid. Together we remain committed to providing delicious plant-based nutrition to our much-valued clients".

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors
Mr. J. Craig Goodwin
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com

About Naturally Splendid Enterprises Ltd.

NSE operates a Safe Quality Food Level 2 certified food manufacturing facility just outside Vancouver, BC in Canada. The Company has established numerous healthy, functional foods under recognized brands such as Natera Sportâ„¢, Natera Hemp Foods, CHII, Elevate Meâ„¢ and Woods Wild Barâ„¢, and most recently Natera Plant Based Foods, a line of plant-based meat alternatives for the rapidly growing plant-based market segment. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE, through its joint venture Plasm Pharmaceutical, has been approved for conducting a phase 2 clinical trial approved by Health Canada for treatment of COVID-19. NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp. NSE contract manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Naturally Splendid Enterprises Ltd.



View source version on accesswire.com:
https://www.accesswire.com/628301/Naturally-Splendid-Receives-Business-Excellence-Award-from-Chamber-of-Commerce

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)

AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE

Amgen (NASDAQ:AMGN) will present at the 7th Annual Evercore HealthCONx Conference at 10:00 a.m. ET on Wednesday, Dec. 4, 2024 . Peter Griffith executive vice president and chief financial officer at Amgen, Jay Bradner executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

Cleo Diagnostics (COV:AU) has announced The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

Download the PDF here.

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight

MariTide is the First Obesity Treatment With Monthly or Less Frequent Dosing to Demonstrate Safe and Effective Weight Loss in a Phase 2 Study

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM

Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 5 a.m. PT on Tuesday, Nov. 26, 2024 to discuss data from the 52-week, Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133) and progress on its development program. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
  BPH Global Ltd

Seaweed Consultancy Renewed – Focus on Blockchain, Carbon Credits and AI to Drive R&D Program

The Board of BPH Global Ltd (ASX: BP8) (Company), is pleased to advise the re-appointment of Gaia Mariculture Pte Ltd (Gaia Mariculture) as the manager of the Company’s research and development programs (R&D Programs). Pursuant to the renewed consulting agreement, the Company’s wholly owned, Singapore-based subsidiary Stemcell United Pte Ltd (BP8 Singapore) has engaged Gaia Mariculture as a to manage the BP8 Group’s R&D Programs (Consulting Agreement).

Keep reading...Show less

Latest Press Releases

Related News

×